Smell Loss: Clinical Trials

1 trial for Smell Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Smell Loss: new trials by email Literature Review of Smell Loss trials Research Report on Smell Loss

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Insulin for COVID-19-related Smell Loss
Insulin - Anosmia, Smell Loss
Phase 3CompletedUniversidad Panamericana272021-01-042022-07-18

Narrower conditions

Anosmia (1)  ·  COVID-19 (1)  ·  Olfaction Disorders (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nidovirales Infections (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Insulin (1)

Sponsors

Universidad Panamericana (1)

Countries

Mexico (1)

Results publications

PMID 29557250, PMID 33862126